Home Online Features Saol Therapeutics Announces Major Clinical Milestones Across Multiple Development Programs
Saol Therapeutics Announces Major Clinical Milestones Across Multiple Development Programs
Hand-out
Press Releases
Saol Therapeutics  
April 18, 2025

Saol Therapeutics Announces Major Clinical Milestones Across Multiple Development Programs

SL1009 targets a 2025 FDA decision for Pyruvate Dehydrogenase Complex Deficiency (PDCD), while SL1002 advances toward Phase III trials for osteoarthritis knee pain and spasticity

Salamanca Press

Local & Social
Latest news for you
Cattaraugus County Source
ePaper
google_play
app_store
This Week's Ads
Current e-Edition
ePaper
google_play
app_store
Already a subscriber? Click the image to view the latest e-edition.
Don't have a subscription? Click here to see our subscription options.
Mobile App

Download Now

The Salamanca Press mobile app brings you the latest local breaking news, updates, and more. Read the Salamanca Press on your mobile device just as it appears in print.

ePaper
google_play
app_store
Trending Recipes

Help Our Community

Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!